Table 2.
Managements of patients and outcomes
| Patient Number | Abscess size (mm) | Drainage | Splenectomy | Culture | Antibiotics | ICU | Mortality |
|---|---|---|---|---|---|---|---|
| P9 | 103 | + | E. Coli | Piperacilline/Tazobactame, Metronidazole | |||
| P10 | 95 | + | E. Coli | Ampicilline/Sulbactame | |||
| P11 | 60 | + | Ceftriaxone, Metronidazole | ||||
| P12 | 100 | + | Ampicilline | + | M | ||
| P13 | 110 and 15 | + | Ceftriaxone, Metronidazole | ||||
| P14 | 90 | + | ---- | ||||
| P15 | 155 | + | Salmonella | Meropenem/Teicoplanine | |||
| P16 | 45 | + | Ceftriaxone, Metronidazole/Ertapenem | ||||
| P2 | 55 and 22 | + | Ceftriaxone | ||||
| P3 | 150 | + | Ceftriaxone, Metronidazole | ||||
| P4 | 70 | + | ----- | ||||
| P5 | 27 | + | Cefepime/Vancomycine, Metronidazole | ||||
| P7 | + | ---- | |||||
| P1 | 115 | + | + | E. Coli | Meropenem, Vancomycin, Polymixine | + | M |
| P6 | 70 | + | + | Ceftriaxone, Metronidazole | M | ||
| P8 | 57 and 15 | + | + | E. Coli |
Ampicilline/Sulbactame, Piperacilline/Tazobactame, |
E.coli: Escherichia coli, ICU: Intensive Care Unit, M:mortality